Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 13801-13850 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04304040
A Study of MIL62 Combined With Orelabrutinib for the Treatment of R/R CD20+B Cell Lymphoma
PHASE1/PHASE2
Active, not recruiting
43 participants
Started: Jul 28, 2020 · Completed: Dec 30, 2025
2 conditions
1 sponsor
10 locations
NCT04483960
Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial
PHASE3
Active, not recruiting
2,200 participants
Started: Jul 28, 2020 · Completed: Dec 31, 2025
1 condition
6 sponsors
25 locations
NCT04395989
An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC.
PHASE2
Active, not recruiting
139 participants
Started: Jul 28, 2020 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04403620
HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck Cancer
PHASE1/PHASE2
Active, not recruiting
59 participants
Started: Jul 28, 2020 · Completed: Aug 31, 2027
1 condition
1 sponsor
1 location
NCT04435756
A Study of MiRNA 371 in Patients with Germ Cell Tumors
N/A
Active, not recruiting
956 participants
Started: Jul 28, 2020 · Completed: Jan 1, 2028
7 conditions
2 sponsors
424 locations
NCT04293146
Pre- Versus Sub-pectoral Implant-based Breast Reconstruction After Skin-sparing Mastectomy or Nipple-sparing Mastectomy OPBC-02PREPEC
NA
Active, not recruiting
382 participants
Started: Jul 28, 2020 · Completed: Feb 28, 2033
2 conditions
2 sponsors
22 locations
NCT04399018
Development and Prospective Validation of a Standardized Flow Cytometric Assay of Peripheral Blood Neutrophil Myeloperoxidase Expression for Ruling Out Myelodysplastic Syndromes.
N/A
Active, not recruiting
103 participants
Started: Jul 27, 2020 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04486911
Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial
PHASE2
Active, not recruiting
89 participants
Started: Jul 27, 2020 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT05660512
Intracept Intraosseous Basivertebral Nerve Ablation
N/A
Active, not recruiting
150 participants
Started: Jul 27, 2020 · Completed: Jul 31, 2026
1 condition
1 sponsor
3 locations
NCT05782660
Cash Benefits and Reproductive/Perinatal Health
NA
Active, not recruiting
3,615 participants
Started: Jul 27, 2020 · Completed: Aug 31, 2025
3 conditions
2 sponsors
1 location
NCT04490057
A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV
PHASE4
Active, not recruiting
320 participants
Started: Jul 27, 2020 · Completed: Sep 30, 2025
1 condition
2 sponsors
4 locations
NCT04325022
Safety and Effectiveness Study of OR3O™ Dual Mobility System in THA
N/A
Active, not recruiting
177 participants
Started: Jul 27, 2020 · Completed: Jan 31, 2035
2 conditions
1 sponsor
13 locations
NCT04499573
Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL
PHASE1/PHASE2
Active, not recruiting
50 participants
Started: Jul 27, 2020 · Completed: Mar 13, 2027
1 condition
1 sponsor
1 location
NCT04379739
Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
89 participants
Started: Jul 26, 2020 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT04835844
RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation
N/A
Active, not recruiting
49 participants
Started: Jul 24, 2020 · Completed: Jul 1, 2026
1 condition
2 sponsors
1 location
NCT04401020
First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL
PHASE1
Active, not recruiting
47 participants
Started: Jul 24, 2020 · Completed: Mar 17, 2026
1 condition
1 sponsor
16 locations
NCT07187024
Efficacy of an Evidence-based Telehealth Intervention in Modifying Health Behavior
NA
Active, not recruiting
65 participants
Started: Jul 24, 2020 · Completed: Sep 1, 2026
3 conditions
3 sponsors
1 location
NCT05631769
HOST - DAPT Duration According the Bleeding Risk
PHASE4
Active, not recruiting
4,900 participants
Started: Jul 24, 2020 · Completed: Dec 31, 2027
3 conditions
2 sponsors
1 location
NCT04494425
Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer
PHASE3
Active, not recruiting
866 participants
Started: Jul 24, 2020 · Completed: Jun 19, 2026
1 condition
2 sponsors
293 locations
NCT04629105
Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)
PHASE1
Active, not recruiting
70 participants
Started: Jul 24, 2020 · Completed: Jul 31, 2025
2 conditions
1 sponsor
3 locations
NCT04331119
Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas
PHASE2
Active, not recruiting
17 participants
Started: Jul 23, 2020 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04374136
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)
PHASE3
Active, not recruiting
110 participants
Started: Jul 23, 2020 · Completed: Aug 3, 2027
1 condition
2 sponsors
44 locations
NCT04544748
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
PHASE1
Active, not recruiting
48 participants
Started: Jul 22, 2020 · Completed: Jan 31, 2025
3 conditions
1 sponsor
12 locations
NCT04499339
A Phase I/IIa Clinical Trial to Assess Feasibility, Safety and Antitumor Activity of Autologous SLAMF7 CAR-T Cells in Multiple Myeloma
PHASE1/PHASE2
Active, not recruiting
38 participants
Started: Jul 22, 2020 · Completed: Dec 31, 2025
1 condition
2 sponsors
3 locations
NCT04420884
A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors
PHASE1/PHASE2
Active, not recruiting
248 participants
Started: Jul 22, 2020 · Completed: Mar 31, 2026
1 condition
1 sponsor
62 locations
NCT04251806
Sleep-disordered Breathing in Infants With Myelomeningocele
N/A
Active, not recruiting
173 participants
Started: Jul 21, 2020 · Completed: Jul 31, 2026
2 conditions
2 sponsors
9 locations
NCT04333888
A Neurofeedback Booster for Emotion Regulation Therapy
NA
Active, not recruiting
44 participants
Started: Jul 21, 2020 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT05976269
Bilateral Knee Pain and Dry Needling
NA
Active, not recruiting
60 participants
Started: Jul 21, 2020 · Completed: Jul 21, 2030
1 condition
1 sponsor
1 location
NCT04024254
A Study of Serum Folate Levels in Patients Treated With Olaparib
PHASE2/PHASE3
Active, not recruiting
10 participants
Started: Jul 21, 2020 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT04270188
Evolution of Symptoms After Anterior Sacrospinofixation by Autologous Tissues
N/A
Active, not recruiting
66 participants
Started: Jul 21, 2020 · Completed: Jul 11, 2025
1 condition
1 sponsor
1 location
NCT04498780
Hemodynamic Effects of ARNI on Noninvasive Pressure-volume Analysis in Patients With Chronic Heart Failure
N/A
Active, not recruiting
117 participants
Started: Jul 21, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT04390399
Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
PHASE2
Active, not recruiting
328 participants
Started: Jul 21, 2020 · Completed: Oct 31, 2025
1 condition
1 sponsor
4 locations
NCT04191304
A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)
PHASE3
Active, not recruiting
134 participants
Started: Jul 20, 2020 · Completed: Sep 1, 2026
1 condition
1 sponsor
51 locations
NCT04198727
Study of the Impact of DPD Activity on the Efficacy of Capecitabine
PHASE2
Active, not recruiting
155 participants
Started: Jul 20, 2020 · Completed: Jul 31, 2030
1 condition
2 sponsors
5 locations
NCT04270474
Reducing Risk of Dementia Through Deprescribing
NA
Active, not recruiting
344 participants
Started: Jul 20, 2020 · Completed: Jul 30, 2026
2 conditions
2 sponsors
2 locations
NCT04443062
Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer
PHASE2
Active, not recruiting
58 participants
Started: Jul 20, 2020 · Completed: Jan 1, 2026
1 condition
3 sponsors
4 locations
NCT04234568
Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors
PHASE1
Active, not recruiting
33 participants
Started: Jul 20, 2020 · Completed: Mar 14, 2026
2 conditions
1 sponsor
11 locations
NCT04195555
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)
PHASE2
Active, not recruiting
3 participants
Started: Jul 20, 2020 · Completed: May 9, 2026
33 conditions
2 sponsors
174 locations
NCT04334941
Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker
PHASE2
Active, not recruiting
94 participants
Started: Jul 20, 2020 · Completed: Nov 30, 2025
1 condition
1 sponsor
564 locations
NCT03715335
Adolescent Sexually Transmitted Infection Screening in the Emergency Department
NA
Active, not recruiting
70,000 participants
Started: Jul 20, 2020 · Completed: Jul 31, 2025
2 conditions
11 sponsors
5 locations
NCT04129138
Patient and Caregiver Attitudes and Beliefs Regarding Prescription of Intranasal Naloxone Spray for Opioid Overdose
N/A
Active, not recruiting
182 participants
Started: Jul 18, 2020 · Completed: Jun 30, 2026
2 conditions
2 sponsors
1 location
NCT04317105
Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN
PHASE1/PHASE2
Active, not recruiting
102 participants
Started: Jul 17, 2020 · Completed: Dec 31, 2025
3 conditions
1 sponsor
6 locations
NCT04298034
Preeclampsia Postpartum Antihypertensive Treatment
PHASE3
Active, not recruiting
300 participants
Started: Jul 17, 2020 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT06143709
Precision PCI Registry
N/A
Active, not recruiting
1,643 participants
Started: Jul 17, 2020 · Completed: Dec 1, 2025
2 conditions
4 sponsors
1 location
NCT04340570
Effect of Medication Management at Home Via Pharmacy Home Televisits
NA
Active, not recruiting
304 participants
Started: Jul 16, 2020 · Completed: Oct 31, 2025
3 conditions
1 sponsor
2 locations
NCT04404088
Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma
PHASE2
Active, not recruiting
60 participants
Started: Jul 16, 2020 · Completed: Mar 1, 2028
7 conditions
2 sponsors
1 location
NCT03927833
Cycled Phototherapy
NA
Active, not recruiting
1,700 participants
Started: Jul 16, 2020 · Completed: Jul 31, 2027
2 conditions
2 sponsors
19 locations
NCT04208178
Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation
PHASE3
Active, not recruiting
20 participants
Started: Jul 16, 2020 · Completed: Jun 16, 2026
1 condition
1 sponsor
11 locations
NCT04251026
A Study of Tividenofusp Alfa (DNL310) in Pediatric Participants With Hunter Syndrome
PHASE1/PHASE2
Active, not recruiting
47 participants
Started: Jul 16, 2020 · Completed: Feb 28, 2031
1 condition
1 sponsor
7 locations
NCT04737616
Continuous Monitoring and Management of Vaginal Health Via Multifunctional OCT/OCTA/OCE Endoscopy
NA
Active, not recruiting
90 participants
Started: Jul 16, 2020 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
Previous
1
More pages
274
275
276
277
278
279
280
More pages
431
Next